Concall AI

Medi Assist Healthcare Services Limited — Q4 FY25 earnings call

Call held 15 May 2025

Management summary

Medi Assist Healthcare Services Limited reported a strong Q4 and full year FY25, demonstrating robust growth across group and retail segments, outperforming industry averages. The company highlighted its evolution from a traditional TPA to a data-driven Health Benefits Administrator, leveraging technology and AI for enhanced services like fraud detection and cashless claim processing. Strategic investments in technology and acquisitions like Paramount TPA are aimed at strengthening its pan-India platform and unbundling services to drive future growth and profitability.

Highlights

Total income for Q4 FY25 was Rs. 196.6 crore, a growth of 14.9% YoY.
Full year FY25 total income reached Rs. 747.1 Cr, up 14.4% YoY.
Group premiums grew by 12.4% from FY'24 to FY'25, outpacing the industry growth rate of 10.5%.
Retail book grew by 29.4% from FY'24 to FY'25, significantly higher than the industry growth rate of 12.2%.
FY25 EBITDA was Rs. 154.1 Cr, representing a 21.3% margin and a 15.6% YoY growth.
PAT for FY25 was Rs. 91.6 Cr, a 28.5% YoY growth, with a 12.3% margin on total income.
Fraud prevention efforts in FY'24 resulted in Rs. 400 crores of savings for insurers, 1.5x the previous year.
Regulatory approval for 100% equity shareholding in Paramount Health Services & Insurance TPA Private Limited was received.

Key financials

4 periods

Headline

Net Cash Balance (Mar 31, 2025)
₹312.1 Cr
Net Worth (Mar 31, 2025)
₹552.2 Cr

Q4

Total Income
₹196.6 Cr
YoY +14.9%
Revenue from Contracts
₹188.9 Cr
YoY +13.2%
EBITDA
₹40.7 Cr
YoY +10.1%
EBITDA Margin
21.6%
PAT
₹21.6 Cr
YoY -15.9%
PAT Margin
11%

FY25

Total Income
₹747.1 Cr
YoY +14.4%
Revenue from Contracts
₹723.3 Cr
YoY +14%
EBITDA
₹154.1 Cr
YoY +15.6%
EBITDA Margin
21.3%
PAT
₹91.6 Cr
YoY +28.5%
PAT Margin
12.3%
Return on Net Worth
16.6%
Return on Capital Employed
18.7%

Non-Govt FY25

Revenue per Headcount
₹14.2 lakh

What they filed

Q1 FY27: revenue up 34.1%, net profit up 62.5% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	39	34	43	44	61 +56%	57 +68%	64 +49%	59 +34%
Expenses	22	27	22	29	36	40	40	42
EBITDA	17	7	20	14	25 +47%	18 +157%	24 +20%	17 +21%
Margin	44%	21%	47%	33%	41%	31%	38%	28%
Other income	3	2	1	2	3	4	5	7
Interest	1	1	1	1	0	1	5	1
Depreciation	5	5	5	5	5	5	5	5
Profit before tax	15	4	15	11	23 +53%	16 +300%	19 +27%	18 +64%
Tax rate	32%	-1%	27%	26%	23%	25%	25%	26%
Net profit	10	4	11	8	18 +80%	12 +200%	14 +27%	13 +63%
EPS	1.44	0.52	1.52	1.14	2.50	1.59	1.94	1.76

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

Group Business
30.3% Market Share95% Retention12.4% Premiums Growth (FY25)42% Private & SAHI Premiums Growth
Retail Business
29.4% Book Growth (FY25)
International Private Medical Insurance (Mayfair)
71% Active Membership Growth
Government Business
24% Revenues Growth (FY25)
Technology Contracts (SaaS)
1.5% Revenue Contribution2% Revenue Contribution (Max)

Guidance & targets

Technology Investment

Investment as % of Revenues Technology Investment · annually · High confidence 5% to 7%

We continue to invest annually about 5% to 7% of our revenues in technology to build core differentiation and innovation.

— Satish Gidugu, Chief Executive Officer

Market Share

Market Share Improvement Market Share · ongoing · Medium confidence improved

And we have improved our market share both in group and retail.

— Satish Gidugu, Chief Executive Officer

Organic Growth

Group & Retail Growth Rates Organic Growth · ongoing · Medium confidence track to or be better than industry growth rates

So from an organic and same store growth perspective, we have always maintained that our growth rates in group and retail will track to or be better than the industry growth rates in the respective segments.

— Satish Gidugu, Chief Executive Officer

Growth Driver

Mayfair Contribution Growth Driver · ongoing · Medium confidence continue to be a growth driver

and we are hopeful that Mayfair will continue to be a growth driver as we continue to integrate into those portfolios.

— Satish Gidugu, Chief Executive Officer

Dividend

Dividend Payout Decision Dividend · next quarter · Low confidence deferred, to be revisited next quarter

But at this point, the board has deferred the decision on whether we will announce dividends and when and how much. We do have another quarter where we can come back with that detail.

— Niraj Didwania, Senior Vice President (Strategy)

Fundraise

Fundraise Timing/Quantum Fundraise · next 12 months · Low confidence no further timing, quantum or usage announced

So on the fund raise, we have always maintained that it was an enabling resolution at the board and that is valid for 12 months. We have not announced any further timing, quantum or usage of that.

— Niraj Didwania, Senior Vice President (Strategy)

Risks & concerns

Slowdown in underlying employment growth (formal employment, IT/ITeS) impacting group business.
medium

Group business growth is partly driven by employer's employee segment, which has seen a slowdown in formal employment, especially in IT/ITeS.

Management acknowledged
Muted industry growth impacting organic growth targets.
medium

If industry growth remains muted, achieving historical organic growth rates of 15-18% could be challenging, though Medi Assist aims to outpace industry.

Analyst acknowledged
Cyclicality in employment generation vs. benefits expansion.
low

The current corporate growth is largely driven by benefits expansion (newer treatments, outpatient flexible benefits) rather than pure employment growth, which is a cyclical phenomenon.

Management acknowledged

Areas of evasion (2)

Specific timing/quantum of fundraise
Specific timing of dividend payout

Q&A highlights

3 direct

Evolution from TPA to Health Benefits Administrator and its impact on margins Direct

So you are right. We have always maintained that we will continue to invest in technology and forward looking opportunities. But as you can hear from Doctor that we have already seen pay out from these technologies or investments in the form of insurance companies recognizing the value we bring to the table from these investments. And we are truly able to unbundle these services. ... And second is they should be far more accretive than the current business because we are leveraging. This is pure form of operating leverage for us where the same expenses are able to deliver more for us.

This question directly addresses the strategic shift and its financial implications, with management confirming positive impact on margins through operating leverage.

Asked by Chintan Sheth

Discrepancy in reported retail premium under management figures Direct

So, Nidhesh, the Rs. 2,341 crore is without the adjustment of the Raksha premiums on pro-rata basis. So that was the reported number on Slide #11 for last year. And Slide #5 is actually with the footnote that we have mentioned that we are, if we allocate on pro rata basis Raksha premium in proportion to what consolidated revenues we took for that period, then the number would be slightly lower because we cannot take the full consolidation. It was only 7 months.

Clarifies a potential inconsistency in reported numbers, ensuring investors have accurate data for analysis.

Asked by Nidhesh Jain

Revenue model for unbundled services (fraud detection, SaaS) and opportunity size Direct

So, our traditional revenue models, as you are aware, in the TPA business, which is currently still 90% of our revenue, is fee-based revenue as a percentage of premium. ... If you do look at our revenue split, if you looked at the government and Mayfair and excluded those, we currently have about a 1.5% to 2% of our revenues from technology contracts. These are typically SaaS contracts. ... But I think it's best to look at them as a SaaS offering from a technology and a platform perspective, the whole pricing model.

Provides insight into the evolving revenue streams beyond the traditional TPA model, highlighting the monetization strategy for new technology-driven services.

Asked by Prithvish Uppal

3 min read 6 chapters

Detailed narrative

Strong Financial Performance in Q4 and FY25

Medi Assist reported a robust financial performance for Q4 FY25 and the full fiscal year. Q4 FY25 total income grew by 14.9% YoY to Rs. 196.6 crore, with revenues from contracts increasing by 13.2% YoY to Rs. 188.9 crore. For the full year FY25, total income reached Rs. 747.1 Cr, marking a 14.4% YoY growth, and revenues from contracts stood at Rs. 723.3 Cr, up 14% YoY. The company achieved an EBITDA of Rs. 154.1 Cr for FY25, translating to a 21.3% margin and a 15.6% YoY growth, while PAT grew by 28.5% YoY to Rs. 91.6 Cr, with a 12.3% margin.

Outpacing Industry Growth in Key Segments

The company demonstrated strong market share gains and growth across its core segments. In the group business, Medi Assist maintained a 30.3% market share with a 95% retention rate and grew its premiums by 12.4% from FY'24 to FY'25, surpassing the industry growth rate of 10.5%. The retail book showed even stronger performance, growing by 29.4% YoY against an industry growth rate of 12.2%. The international private medical insurance (IPMI) segment, driven by Mayfair, saw active membership grow by 71%, and government revenues increased by over 24% YoY.

Evolution to Health Benefits Administrator & Technology Leverage

Medi Assist is strategically evolving from a pure Third-Party Administrator (TPA) to a Health Benefits Administrator, leveraging data, technology, and AI/ML. The company invests 5% to 7% of its revenues annually in technology, which has enabled services beyond claims processing, including fraud detection, network enablement, and predictive analytics. These efforts resulted in Rs. 400 crores of savings for insurers from fraud prevention in FY'24, a 1.5x increase from the previous year. Two insurers currently operate on Medi Assist's claims management platform, and 19 use its hospital network.

Unbundling Services and New Revenue Models

The unbundling of services allows Medi Assist to engage with a wider set of stakeholders and monetize capabilities independently of traditional TPA contracts. While 90% of current revenue remains fee-based as a percentage of premium from the TPA business, technology contracts (SaaS-based, API access) now contribute 1.5% to 2% of revenues (excluding government and Mayfair). Management expects these unbundled services to be "far more accretive" due to operating leverage, as existing investments are leveraged for new offerings.

Paramount Acquisition and Strategic Outlook

Medi Assist recently received regulatory approval to acquire 100% equity shareholding in Paramount Health Services & Insurance TPA Private Limited. This acquisition is aimed at strengthening the company's geographic presence, insurer relationships, and building a truly pan-India platform for seamless service delivery. Management views this as a "great historic moment" and expects it to further enhance their ability to serve the ecosystem.

Capital Allocation and Dividend Policy

The company reported a strong balance sheet with a net cash balance of INR 312.1 Cr as of March 31, 2025, and a net worth of Rs. 552.2 Cr. Return on net worth was 16.6%, and return on capital employed was 18.7%. While there is a stated commitment to consistently reward shareholders through dividends, the board has deferred the decision on dividend payout for this quarter, stating they will revisit it in the coming quarter based on capital allocation requirements and growth investment needs. The fundraise resolution is an enabling one, with no specific timing or quantum announced.

This is an AI-generated summary of a publicly available earnings call transcript.

View original transcript